Literature DB >> 18942759

Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis.

Kayoko Matsumura, Hiroshi Nakase, Shuji Yamamoto, Takuya Yoshino, Yasuhiro Takeda, Katsuhiro Kasahara, Satoru Ueno, Norimitsu Uza, Tsutomu Chiba.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 18942759     DOI： 10.1002/ibd.20760

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  7 in total

1.  Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.

Authors:  Xiaochang Liu; Jianming Xu; Qiao Mei; Liang Han; Jian Huang
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

2.  Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis.

Authors:  Reiko Akitake; Hiroshi Nakase; Masashi Tamaoki; Satoru Ueno; Sakae Mikami; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2009-08-12       Impact factor: 3.199

3.  Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease.

Authors:  Kyoichi Kato; Ken Fukunaga; Koji Kamikozuru; Shinichiro Kashiwamura; Nobuyuki Hida; Yoshio Ohda; Naohisa Takeda; Koji Yoshida; Masaki Iimuro; Yoko Yokoyama; Risa Kikuyama; Hiroto Miwa; Takayuki Matsumoto
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

4.  Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice.

Authors:  Zhenglei Xu; Cheng Wei; R U Zhang; Jun Yao; Dinguo Zhang; Lisheng Wang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

Review 5.  Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent update.

Authors:  Yuan Guo; Nonghua Lu; Aiping Bai
Journal:  Biomed Res Int       Date:  2013-01-21       Impact factor: 3.411

Review 6.  Concomitant Thyroid Disorders and Inflammatory Bowel Disease: A Literature Review.

Authors:  Toru Shizuma
Journal:  Biomed Res Int       Date:  2016-03-03       Impact factor: 3.411

7.  A Role of Exopolysaccharide Produced by Streptococcus thermophilus in the Intestinal Inflammation and Mucosal Barrier in Caco-2 Monolayer and Dextran Sulphate Sodium-Induced Experimental Murine Colitis.

Authors:  Yun Chen; Ming Zhang; Fazheng Ren
Journal:  Molecules       Date:  2019-01-31       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.